Drug Trial Radar · NCT07384975
A Study to Assess NAV-240 in Adult Participants With Hidradenitis Suppurativa
Last checked: Nov 20, 2026Latest source record: Jul 22, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
150
Planned (sponsor's estimate)
Start
Jan 5, 2026
Primary completion
Sep 2027
Study completion Oct 2027
Sponsor
- Lead sponsor
- Navigator Medicines, Inc.Industry
- Sponsor type
- Industry
- First posted
- Feb 3, 2026
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 70 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The main objective of this study is to determine if NAV-240 works more effectively than a dummy treatment (placebo) for participants with moderate-to-severe HS. The main endpoint of this study is the percentage of participants achieving Hidradenitis Suppurativa Clinical Response (HiSCR) 75 at Week 16, meaning at least a 75% reduction in inflamed skin bumps (abscess and inflammatory nodule (AN) count) with no increase in number of abscesses or draining tunnels (channels under the skin that leak fluid or pus) compared to the baseline (start of the study). Participants will: * Receive NAV-240 dose 1, NAV-240 dose 2 or placebo as a drip into the veins (intravenous infusion). * Visit the clinic up to 9 times for checkups and tests over 22 weeks. * Complete a daily diary about their skin pain.
Conditions
- Hidradenitis Suppurativa (HS)
Interventions
NAV-240Drug
NAV-240 for Intravenous Infusion
Placebo to match NAV-240Drug
Placebo to match NAV-240 for Intravenous Infusion
Primary outcomes
What the sponsor says the trial is designed to measure.
- Proportion of participants achieving Hidradenitis Suppurativa Clinical Response (HiSCR) 75Time frame: Baseline to Week 16
Locations
41 sites in 8 countries. Site status is shown where the registry gives one.
Medical Dermatology Specialist
Phoenix, Arizona · Recruiting
Scottsdale Clinical Trials
Scottsdale, Arizona · Recruiting
Accel Research Sites Network
Maitland, Florida · Recruiting
Floridian Research Institute
Miami, Florida · Recruiting
Cordova Research Institute
Miami, Florida · Recruiting
Ziaderm Research, LLC
North Miami Beach, Florida · Recruiting
FWD Clinical Research
Tamarac, Florida · Recruiting
MplusM - D&H Tamarac Research Center
Tamarac, Florida · Recruiting
ForCare Clinical Research
Tampa, Florida · Recruiting
Kentucky Advanced Medical Research LLC
Murray, Kentucky · Recruiting
Beth Israel Deaconess Medical Center
Boston, Massachusetts · Recruiting
SKY Integrative Medical Center
Ridgeland, Mississippi · Recruiting
StracSkin, PLLC
Portsmouth, New Hampshire · Recruiting
Equity Medical, LLC
The Bronx, New York · Recruiting
Medical Center Medconsult Pleven
Lovech, Bulgaria · Recruiting
MC Medconsult Pleven
Pleven, Bulgaria · Recruiting
Ambulatory for Specialized Medical Help - skin and venereal diseases
Sofia, Bulgaria · Recruiting
Diagnostic Consultative Center Fokus-5 Medical Establishment for Outpatient Care EOOD
Sofia, Bulgaria · Recruiting
FACET Dermatology
Toronto, Ontario, Canada · Recruiting
Research Toronto
Toronto, Ontario, Canada · Recruiting
Centre de Recherche Saint-Louis (Quebec)
Montreal, Quebec, Canada · Recruiting
LTD Aversi Clinic - Dermatology
Tbilisi, Georgia · Recruiting
LTD Israel-Georgian Medical Research Clinic Healthycore
Tbilisi, Georgia · Recruiting
LTD MediClub Georgia
Tbilisi, Georgia · Recruiting
LTD Multiprofile Clinic Consilium Medulla
Tbilisi, Georgia · Not yet recruiting
St. Josef Hospital Bochum - Dermatologie, Venerologie und Allergologie
Bochum, Germany · Recruiting
J. W. Goethe Universitaet Frankfurt Zentrum f. Dermatologie
Frankfurt, Germany · Recruiting
Universitaetsklinikum Schleswig-Holstein (UKSH) - Campus Kiel - Klinik fuer Dermatologie, Venerologie und Allergologie
Kiel, Germany · Recruiting
Universitaetsklinikum Schleswig-Holstein (UKSH) - Campus Luebeck
Lübeck, Germany · Recruiting
BAG Dres. med. Quist PartG
Mainz, Germany · Recruiting
Debreceni Egyetem Klinikai Központ - Dermatology
Debrecen, Hungary · Recruiting
Pécsi Tudományegyetem Klinikai Központ - Bőr-, Nemikórtani és Onkoderma
Pécs, Hungary · Recruiting
Holsamed
Katowice, Poland · Recruiting
Dermedic Jacek Zdybski
Kielce, Poland · Recruiting
Labderm Essence
Ossy, Poland · Recruiting
Klinika Ambroziak Dermatologia
Warsaw, Poland · Recruiting
OT CO Zdrowie
Warsaw, Poland · Recruiting
Centrum Columbus
Wroclaw, Poland · Recruiting
Futuremeds Romania - Brasov - Dermatology
Brasov, Romania · Recruiting
Spitalul Clinic Colentina - Dermatology II
Bucharest, Romania · Recruiting
Showing 40 of 41 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.